Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Non-Current Assets (2020 - 2026)

Biomea Fusion (BMEA) posted Non-Current Assets of $67000.0 for Q1 2026, down 87.16% sequentially from $522000.0 in Q4 2025, and down 99.35% YoY from $10.4 million in Q1 2025.

Biomea Fusion (BMEA) Non-Current Assets (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Non-Current Assets for 7 years, with the latest figure at $67000.0 in Q1 2026.

  • Quarterly Non-Current Assets fell 99.35% year-over-year to $67000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (down 74.71% YoY) and the FY2025 annual result came in at $522000.0, down 95.5% from the prior year.
  • Non-Current Assets declined to $67000.0 in Q1 2026 per BMEA's latest filing, from $522000.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $23.7 million in Q1 2023 and troughed at $67000.0 in Q1 2026.
  • A 5-year average of $12.8 million and a median of $11.5 million in 2022 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2023 and 2026: Non-Current Assets surged 264.89% in 2023, then sank 99.35% in 2026.
  • Over 5 years, Non-Current Assets stood at $11.5 million in 2022, then jumped by 80.59% to $20.7 million in 2023, then plunged by 44.06% to $11.6 million in 2024, then sank by 95.5% to $522000.0 in 2025, then slumped by 87.16% to $67000.0 in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $67000.0, $522000.0, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.15 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.96 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 938.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 468.65 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 18.06 Bn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 445,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 445,000.00
Mar 31, 2026 67,000.00
Dec 31, 2025 522,000.00
Sep 30, 2025 5.75 Mn
Jun 30, 2025 8.50 Mn
Mar 31, 2025 10.37 Mn
Dec 31, 2024 11.61 Mn
Sep 30, 2024 16.82 Mn
Jun 30, 2024 19.88 Mn
Mar 31, 2024 20.93 Mn
Dec 31, 2023 20.75 Mn
Sep 30, 2023 22.58 Mn
Jun 30, 2023 22.74 Mn
Mar 31, 2023 23.71 Mn
Dec 31, 2022 11.49 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 7.60 Mn
Mar 31, 2022 7.84 Mn
Dec 31, 2021 9.14 Mn
Sep 30, 2021 8.30 Mn